Pieris Pharmaceuticals develops therapeutic proteins known as anticalins, which are derived from naturally occurring proteins found in human bodily fluids. Their drug candidates include treatments for respiratory disease, lung fibrosis, and various cancers. They have partnerships and collaborations with a variety of pharmaceutical and research organizations, and were founded in 2000 and are based in Boston.